{
  "slug": "angiodynamics",
  "name": "AngioDynamics",
  "description": "AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. Their portfolio includes products for vascular access, peripheral vascular intervention, and oncology/surgery.",
  "url": "https://optimly.ai/brand/angiodynamics",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://angiodynamics.co/",
  "baiScore": 38,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-15T01:28:25.977Z",
  "verifiedVitals": {
    "website": "angiodynamics.com",
    "founded": "1988",
    "headquarters": "Latham, New York, USA",
    "pricing_model": "B2B sales, capital equipment sales, disposable product sales, service contracts.",
    "core_products": "Vascular access (e.g., PICCs, Midlines), Peripheral Vascular Intervention (e.g., Auryon atherectomy, mechanical thrombectomy), Oncology/Surgery (e.g., NanoKnife, microwave ablation).",
    "key_differentiator": "Portfolio of innovative, minimally invasive devices addressing significant clinical needs in oncology and vascular health, including unique technologies like NanoKnife's IRE.",
    "target_markets": "Hospitals, outpatient clinics, interventional radiology, interventional cardiology, surgical oncology, vascular surgery.",
    "employee_count": "1,000-5,000",
    "funding_stage": "Publicly Traded",
    "subcategory": "Medical Devices"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional open surgery: For conditions like peripheral artery disease or certain cancers, alternatives might involve more invasive surgical procedures instead of AngioDynamics' minimally invasive de",
      "Specialized contract research organization (CRO): Instead of using in-house clinical data or directly engaging with AngioDynamics, healthcare providers might rely on independent CROs for research and ",
      "Symptomatic management without intervention: In some cases, patients might opt for palliative care or symptomatic management without device-based intervention, depending on the condition and patient p"
    ],
    "solutionIntents": [
      "AngioDynamics medical devices",
      "NanoKnife cancer treatment",
      "AngioDynamics stock",
      "Auryon atherectomy system",
      "AngioDynamics direct competitors",
      "Alternative imaging modalities: For diagnosis or guidance, alternative imaging systems or less specialized devices from other manufacturers could be used."
    ],
    "evaluationIntents": []
  },
  "timestamp": 1784110557399
}